Cardio protection with dulaglutide is not depending on baseline therapy with metformin: a subgroup analysis of the REWIND trialG. Ferrannini,H. C. Gerstein,H. M. Colhoun, G. R. Dagenais,R. Diaz, L. Dyal,M. Lakshmanan,L. Mellbin, J. Probstfield, M. C. Riddle, J. E. Shaw,L. RydenDIABETOLOGIA（2020）引用 2|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
